ALI ABADY: Open Payments
NPI 1790268795 · WESTERVILLE, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$754 in 37 payments from 11 companies in 2025. Trend: 2023 $1,416 · 2024 $1,468 · 2025 $754
Food & beverage: $754
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 11 | $202 |
| AstraZeneca Pharmaceuticals LP | 5 | $150 |
| Novo Nordisk Inc | 4 | $69 |
| Xeris Pharmaceuticals, Inc. | 3 | $68 |
| Astellas Pharma US Inc | 2 | $57 |
| GlaxoSmithKline, LLC. | 3 | $51 |
| Lilly USA, LLC | 3 | $49 |
| Amgen Inc. | 2 | $36 |
| PFIZER INC. | 2 | $34 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $19 |
Products named: QULIPTA, UBRELVY, FARXIGA, GVOKE HYPOPEN, AIRSUPRA, Veozah, TRELEGY ELLIPTA, NURTEC ODT.
Industry payments across OH — which companies pay providers there.
